Diverse Mechanisms for 
Inflammatory Disease

Nucleome’s technology generates a highly productive repeatable process for the discovery of novel therapeutic targets. In addition to developing its own pipeline of inflammatory disease medicines, Nucleome is selectively partnering with pharmaceutical companies and expanding its approach to address additional applications and therapeutic areas.